23 completed, 9 unknown, 4 recruiting, 1 active not recruiting. 4 Phase 4, 3 Not applicable, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Bone and Joint Infection: new trials by email Literature Review of Bone and Joint Infection trials Research Report on Bone and Joint Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ultralow Dose PET Imaging for 18F-NaF Uptake 18F-NaF - Healthy Volunteer, Bone Alteration | Phase 2 | Recruiting | Akiva Mintz | 200 | 2025-09-01 | 2025-12-16 |
| Initial Oral Antibiotics for Bone and Joint Infections in Children Oral antibiotic treatment - Osteomyelitis Acute, Septic Arthritis | Recruiting | Copenhagen University Hospital, Rigshospitalet | 100 | 2024-11-15 | 2025-04-09 | |
| Comparing Oral Versus Parenteral Antimicrobial Therapy Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection | Phase 4 | Terminated | West Virginia University | 94 | 2023-08-04 | 2025-08-26 |
| Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection Omadacycline Pill, Standard of Care - Bone Infection, Joint Infection | Phase 2 | Active not recruiting | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 180 | 2023-05-09 | 2026-01-14 |
| Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip sampling blood, Sampling synovial fluid, Sampling bone tissue - PJI, Bone and Joint Infection | Phase 4 | Unknown | Radboud University Medical Center | 30 | 2022-09-01 | 2022-06-16 |
| Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home pharmaceutical interview - Bone and Joint Infection | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 90 | 2022-03-22 | 2024-12-04 |
| Lyon PJI Retrospective Cohort Study PJI - Bone and Joint Infection | Unknown | Hospices Civils de Lyon | 400 | 2022-01-10 | 2022-01-20 | |
| Recurrent S. Aureus Infections in Osteoarticular Infections relapse due to S. aureus - Staphylococcus Aureus Infection, Bone and Joint Infection | Unknown | Hospices Civils de Lyon | 40 | 2021-08-01 | 2022-01-20 | |
| Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections patients having had BJI or PJI treated with daptomycin - Dactinomycin Adverse Reaction, Bone and Joint Infection | Unknown | Hospices Civils de Lyon | 1130 | 2021-06-15 | 2022-05-06 | |
| BonE and Joint Infections - Simplifying Treatment in Children Trial Oral cefalexin only, IV cefazolin or IV flucloxacillin followed by oral cefalexin - Bone Infection, Septic Arthritis | Phase 4 | Recruiting | Murdoch Childrens Research Institute | 214 | 2021-06-01 | 2026-10-27 |
| Phage Safety Retrospective Cohort Study patients having had avderse event after phagotherapy for bone or joint or implant infection - Bone and Joint Infection, Prosthetic Joint Infection | Unknown | Hospices Civils de Lyon | 25 | 2021-02-01 | 2023-04-13 | |
| Tedizolid Suppressive Antimicrobial Therapy in a Reference Center patients having had a BJI/PJI treated with tedizolid as a suppressive antibiotic therapy - Bone and Joint Infection | Completed | Hospices Civils de Lyon | 17 | 2021-02-01 | 2021-06-21 | |
| Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections Patients having had an osteo-articular infection with Stahylococcus - Bone and Joint Infection, Staphylococcus | Completed | Hospices Civils de Lyon | 50 | 2020-12-01 | 2025-12-19 | |
| Oral-only Antibiotics for Bone and Joint Infections in Children Oral co-amoxiclav or oral dicloxacillin only, IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin - Osteomyelitis, Septic Arthritis | Phase 4 | Completed | Copenhagen University Hospital, Rigshospitalet | 180 | 2020-09-15 | 2025-04-13 |
| Ofloxacin Concentration-toxicity Relationship in the Elderly ofloxacin, questionnaire, Ofloxacin Serum concentration - Ofloxacin, Bone and Joint Infection | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 110 | 2020-06-02 | 2025-06-10 |
| Septic Management and Outcome of Open Fracture management and follow up of all open fractures - Open Fracture, Pseudarthrosis | Completed | Hospices Civils de Lyon | 400 | 2020-05-15 | 2022-01-12 | |
| Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI Description of use of ceftaroline and ceftobiprole - Bone and Joint Infection, Antibiotic Reaction | Completed | Hospices Civils de Lyon | 22 | 2020-02-01 | 2020-06-05 | |
| Infection After Free Fibula Flap Reconstruction of the Mandible: a Retrospective Cohort Study failure of reconstruction of the mandibule by free fibula flap - Bone and Joint Infection | Completed | Hospices Civils de Lyon | 30 | 2019-06-01 | 2023-09-22 | |
| Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin Description of eosinophilic pneumonia due to daptomycine - Dactinomycin Adverse Reaction, Bone and Joint Infection | Unknown | Hospices Civils de Lyon | 20 | 2019-02-19 | 2020-11-09 | |
| Osteoarticular Infections With Pneumococcal Bone and joint infection with Streptococcus peumoniae - Bone and Joint Infection | Completed | Hospices Civils de Lyon | 33 | 2019-01-01 | 2023-09-22 |
Showing 20 of 38. Sign in to see all of them.
Osteomyelitis (5) · Staphylococcal Infections (4) · Arthritis, Infectious (3) · Pulmonary Eosinophilia (3) · Recurrence (3) · Drug-Related Side Effects and Adverse Reactions (2) · Infections (2) · Acute Kidney Injury (1) · Arthritis (1) · Bacterial Infections (1) · Fractures, Open (1) · Medication Adherence (1) · Otitis (1) · Persistent Infection (1) · Pseudarthrosis (1)
Infections (10) · Musculoskeletal Diseases (7) · Bacterial Infections and Mycoses (5) · Bone Diseases (5) · Bone Diseases, Infectious (5) · Bacterial Infections (4) · Disease Attributes (4) · Gram-Positive Bacterial Infections (4) · Joint Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Arthritis (3) · Eosinophilia (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3)
Amoxicillin-Potassium Clavulanate Combination (2) · Cefazolin (2) · Daptomycin (2) · tedizolid (2) · Amoxicillin (1) · Ampicillin (1) · Blood Specimen Collection (1) · Cefadroxil (1) · Cefepime (1) · Cefoxitin (1) · Cefpodoxime (1) · Ceftaroline (1) · Ceftazidime (1) · Cephalexin (1) · Ciprofloxacin (1)
Hospices Civils de Lyon (27) · Copenhagen University Hospital, Rigshospitalet (2) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2) · Akiva Mintz (1) · Assistance Publique - Hôpitaux de Paris (1) · Centre Hospitalier Universitaire, Amiens (1) · MaaT Pharma (1) · Murdoch Childrens Research Institute (1) · Radboud University Medical Center (1) · West Virginia University (1)
France (27) · United States (4) · Denmark (2) · Australia (1) · Ireland (1) · New Zealand (1)
Tristan Ferry, Md,PhD (4) · Tristan Ferry, MD, PhD (2) · Allan Bybeck Nielsen, MD (1) · Amanda Gwee, PhD (1) · Amy Y. Kang, PharmD, BCIDP (1) · Arif R. Sarwari, MD, MSc, MBA (1) · Christophe Menigaux, MD (1) · Florent Valour, Md,PhD (1) · Jessica Berdougo Berdougo, PharmD (1) · Jon Goosen, MD, PhD (1) · Joy J. Juskowich, MD (1) · Loren G Miller, MD MPH (1)